MPM Capital and Dana-Farber Cancer Institute raise $100m for new fund

MPM Capital and Dana-Farber Cancer Institute have raised $100 million for a new fund that will invest in early-stage biotech companies developing oncology therapeutic technologies.

FundraisingFundraisingHealthcareBriefs